JP2003246728A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003246728A5 JP2003246728A5 JP2002369185A JP2002369185A JP2003246728A5 JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5 JP 2002369185 A JP2002369185 A JP 2002369185A JP 2002369185 A JP2002369185 A JP 2002369185A JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- animal
- feed
- salt
- ornithine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 5
- 241001465754 Metazoa Species 0.000 claims 5
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 5
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 5
- 229960003104 ornithine Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 206010063493 Premature ageing Diseases 0.000 claims 3
- 208000032038 Premature aging Diseases 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002369185A JP2003246728A (ja) | 2001-12-21 | 2002-12-20 | クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001389912 | 2001-12-21 | ||
| JP2001-389912 | 2001-12-21 | ||
| JP2002369185A JP2003246728A (ja) | 2001-12-21 | 2002-12-20 | クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003246728A JP2003246728A (ja) | 2003-09-02 |
| JP2003246728A5 true JP2003246728A5 (fr) | 2005-08-18 |
Family
ID=28677010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002369185A Pending JP2003246728A (ja) | 2001-12-21 | 2002-12-20 | クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003246728A (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007031375A (ja) * | 2005-07-28 | 2007-02-08 | Kyowa Hakko Kogyo Co Ltd | 肌質改善用経口剤 |
| JP2017019726A (ja) * | 2015-07-07 | 2017-01-26 | 佐々木食品工業株式会社 | Ｅｌｏｖｌ６阻害、ＮＡＳＨの予防又は治療並びにインスリン抵抗性改善用組成物 |
| EP4144413A4 (fr) * | 2020-03-30 | 2024-04-24 | Ajinomoto Co., Inc. | Composition permettant d'améliorer ou de prévenir des baisses de la résistance osseuse |
| WO2026038577A1 (fr) * | 2024-08-15 | 2026-02-19 | 太陽化学株式会社 | Composition pour réguler la concentration d'acide aminé dans le sang ou d'hormones gastro-intestinales après ingestion d'aliments et de boissons |
-
2002
- 2002-12-20 JP JP2002369185A patent/JP2003246728A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY176679A (en) | Use of nutritional compositions for preventing disorders | |
| MY151018A (en) | Use of nutritional compositions for preventing disorders | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MXPA04005582A (es) | Alimento o composicion de alimento para mascotas que contiene extracto de plantas para la salud osea. | |
| EP1356811A4 (fr) | Agents prophylactiques ou remedes contre l'arthrite | |
| WO2005007652A3 (fr) | Analogues de quinoline-4-ylamine substituee | |
| WO2009055799A3 (fr) | Compositions et procédés de traitement de maladies sur le pied d'un animal | |
| WO2020158632A1 (fr) | Eau fonctionnelle | |
| WO2004110380A3 (fr) | Traitement des maladies a mediation immunologique au moyen de composes a base de vitamine d active, seuls ou en association avec d'autres agents therapeutiques | |
| WO2006029036A3 (fr) | Therapie combinee avec du glatiramere acetate et de la n-acetylcysteine pour traiter la sclerose en plaques | |
| WO2004093881A3 (fr) | Utilisation du dipyridamole ou du mopidamole pour le traitement et la prevention de maladies thrombo-emboliques et de troubles induits par la formation excessive de thrombine et/ou par l'expression elevee des recepteurs de la thrombine | |
| EP1637137A3 (fr) | Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux | |
| MXPA04000442A (es) | Composicion de alimento para mascotas, para regular el peso corporal y evitar la obesidad y trastornos relacionados en mascotas. | |
| DE60101087D1 (de) | Gesunde hundefuttermittel | |
| JP2008500376A5 (fr) | ||
| ATE409028T1 (de) | Arzneien zur behandlung von nervenerkrankungen | |
| EP1938824A4 (fr) | Médicaments, aliments et boissons ou aliments pour animaux contenant de la sphingomyéline | |
| JP2003246728A5 (fr) | ||
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| Motluk | It's a wonderful lie | |
| WO2004056768A3 (fr) | Utilisation de 2,5-diamidoindoles substitues pour le traitement de maladies urologiques | |
| PL374083A1 (en) | Sgk and nedd used as diagnostic and therapeutic targets | |
| HU0102987D0 (en) | Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| CA2489208A1 (fr) | Agent suppresseur de l'interleukine 6 | |
| WO2004093867A3 (fr) | Sels d'acide phenolique de gabapentine sous une forme galenique liquide ou semi-solide et mode d'utilisation |